Daclizumab ( 达克珠单抗 )

产品名称：Daclizumab ( 达克珠单抗 )；

产品编号：YR1002；

分子名称：Daclizumab；

克隆性：Monoclonal；

产品别称：BIIB019, DAC HYP, Anti-IL-2；

关键词：Anti-IL-2, Humanized antiCD25, Ig gamma-1 chain C region, Anti-Human CD25 Therapeutic AntibodyBIIB019, DAC HYP, Anti-IL-2, Humanized antiCD25, Ig gamma-1 chain C region, Anti-Human CD25 Therapeutic Antibody, Daclizumab, Daclizumab, 达克珠单抗；

规格：1mg, 5mg；

浓度：1mg/ml；

抗体亚型：IgG1 Kappa；

宿主：；

CAS号：152923-56-3；

来源：CHO Cells；

纯度：≥95% as determined by SDS-PAGE；

缓冲体系：Supplied in PBS, PH7.5；

分子量：142612.1 Da；

产品背景：Daclizumab (trade name Zinbryta) is a therapeutic humanized monoclonal antibody which was used for the treatment of adults with relapsing forms of multiple sclerosis (MS). Daclizumab works by binding to CD25, the alpha subunit of the IL-2 receptor of T-cells.；

保存条件：Stored at -20℃ to -80℃.；

运输条件：Shipped on ice packs.；

产品应用：ELISA, Neut, IF, IP, FC, FuncS, MRI；